Skip to main content
. 2020 Oct 29;12(11):3182. doi: 10.3390/cancers12113182

Table 4.

Comparison of the clinical characteristic of iCCA patients with classical risk factors, non-alcoholic steatohepatitis, and no risk factors. Continuous variables have been reported as median (interquartile range). Categorical variables are reported as frequencies (percentages).

Variables NASH Group A (n = 29) No Risk Factors Group B (n = 100) Classical Risk Factors Group C (n = 51) Omnibus p-Value * A vs. B p-Value ** A vs. C p-Value **
Sex (Male) 14 (48.3%) 49 (49.0%) 35 (68.6) 0.056 1.000 0.096
Age (years) 70.0 (58.0–75.5) 66.5 (58.0–72.8) 63.0 (56.0–70.0) 0.120 0.287 -
History of other tumours 7 (24.1%) 21 (21.0%) 10 (19.6) 0.891 0.799 0.777
Hypertension 22 (75.9%) 45 (45.0%) 28 (54.9) 0.013 0.005 0.092
Diabetes 7 (24.1%) 13 (13.0%) 14 (27.5) 0.073 0.085 0.798
Dyslipidemia 8 (27.6%) 22 (22.0%) 11 (21.6) 0.795 0.618 0.591
Body mass index 29.8 (24.1–32.0) 24.2 (22.0–26.7) 26.1 (23.6–28.3) <0.001 0.001 0.030
Severe fibrosis (F3–F4) 6 (20.7) 8 (8.0) 22 (43.1) <0.001 0.084 0.053
Main tumour dimension (mm) 50.0 (30.5–79.0) 65.5 (50.0–95.0) 50.0 (30.0–70.0) 0.003 0.005 1.000
Multinodular disease 10 (34.5%) 25 (25.0%) 15 (29.4) 0.576 0.346 0.802
T
1a 5 (17.2%) 17 (17.0%) 16 (31.4)
1b 4 (13.8%) 34 (34.0%) 10 (19.6)
2 15 (51.7%) 31 (31.0%) 17 (33.0) 0.163 0.511 0.438
3a 3 (10.3%) 8 (8.0%) 2 (3.9)
3b 2 (6.9%) 10 (10.0%) 6 (11.8)
n > 0 28(27.6%) 23 (23.0%) 5 (9.8) 0.085 0.626 0.058
R > 0 9 (31.0%) 31 (31.0%) 9 (17.6) 0.193 1.000 0.178
Adjuvant treatment 12 (41.4%) 42 (42.0%) 22 (43.1) 0.986 1.000 1.000

* Three-group comparisons were performed with the Kruskal–Wallis test for continuous variables and the Pearson Chi-square test for categorical variables. ** The Dunn-Bonferroni test and the Chi-square test for independence with a Bonferroni correction for multiple comparisons were used for the subsequent pairwise comparison of continuous and categorical variables, respectively.